- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05089032
The Practice of Providing Palliative Care in the Situation of the COVID-19 Pandemic (PEOpLeC19-EN)
March 13, 2025 updated by: Jan Malaska, Masaryk University
The Practice of Providing Palliative Care in the Situation of the COVID-19 Pandemic in the Perspective of Physicians and Nurses - Survey Study (PEOpLe-C19-EN Study)
The practice of providing palliative care in the situation of the COVID-19 pandemic in the perspective of physicians and nurses - survey study (PEOpLe-C19 study)
Study Overview
Status
Completed
Conditions
Detailed Description
Pandemic of coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome coronavirus 2) causing the disease COVID-19 (Coronavirus Disease 2019) overwhelmed healthcare and brought new challenges and stressful situations.
In a short time, intensive care units (ICU) capacities were filled in many countries and regions.
Due to the need for an excessive number of patients requiring intensive care, physicians and nurses who do not routinely provide care to critically ill patients or do not have the appropriate training (non-ICU clinician) were involved in the care of COVID-19 patients.
In this context, ICU directly dedicated to caring for patients with COVID-19 ARDS (Acute Respiratory Distress Syndrome) was also opened.
Non-ICU clinicians were more or less involved together with the standard ICU staff in palliative care, including End-of-Life decision (EOLD) making, even in a situation of limited, scarce resources (equipment or personnel).
New workplace and scope of work, which did not correspond to the standard activity or education, most likely led to an increased stress load.
EOLD can also be one of the factors leading to increased stress levels.
The project aims to describe the practice of palliative care for patients with COVID-19 in a situation of pandemic COVID-19 and to identify factors leading to possible moral distress related to EOLD.
Study Type
Observational
Enrollment (Actual)
215
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Brno, Czechia, 62500
- Masaryk university
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Healthcare providers (physicians and nurses) providing care to patients with COVID-19 admitted at ICU in period of COVID-19 pandemic.
Description
Inclusion Criteria:
- Healthcare providers (physicians/nurses)
- Involvement in care for patients with COVID-19 admitted at intensive care unit
Exclusion Criteria:
- Non-ICU staff
- not involved in care for patients with COVID-19
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Nurses
|
|
Physicians
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change of practice of providing palliative care at ICU in COVID-19 pandemic
Time Frame: Through study completion, an average of 1 month
|
Change of practice of providing palliative care including EOLD practice in patients with COVID-19 admitted at ICU during pandemic.
|
Through study completion, an average of 1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identify factors leading to moral distress during the COVID-19 pandemic
Time Frame: Through study completion, an average of 1 month
|
Identify factors leading to moral distress during COVID-19 pandemic and describe possible different risk factors by profession
|
Through study completion, an average of 1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Tereza Prokopova, MD, University Hospital Brno
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2023
Primary Completion (Actual)
February 29, 2024
Study Completion (Actual)
February 29, 2024
Study Registration Dates
First Submitted
October 21, 2021
First Submitted That Met QC Criteria
October 21, 2021
First Posted (Actual)
October 22, 2021
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 13, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PEOpLe-C19-EN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on COVID-19 Pandemic
-
Laval UniversityCISSS de Chaudière-Appalaches; VITAM: Research Center on Sustainable Health; Centre... and other collaboratorsRecruiting
-
Assiut UniversityDoaa M.EL ShehabyUnknownCovid 19 Pandemic From Ethical View
-
University of JordanAysha Alkhayat; Mariam Aljweesri; Reem Alharbi; Zahraa AljazzafCompleted
-
Sialkott College of Physical TherapyCompletedBurnout, Psychological | Covid-19 PandemicPakistan
-
Istituto Auxologico ItalianoUniversity of Bergen; Catholic University of the Sacred Heart; University of... and other collaboratorsCompletedDepression | Anxiety Disorders | Stress | Social Isolation | COVID-19 Pandemic Psychological ImpactItaly
-
University of GaziantepCompleted
-
Charite University, Berlin, GermanyRecruitingAnxiety Related to the COVID-19 PandemicGermany
-
University Hospital, BrestCompletedIdentify Emerging Health Challenges for Children With Motor Disabilities and Their Parents Facing the COVID-19 PandemicFrance
-
Dr. Soetomo General HospitalIndonesia-MoH; Universitas Airlangga; Biotis Pharmaceuticals, IndonesiaRecruitingCOVID-19 Pandemic | COVID-19 Vaccines | COVID-19 Virus DiseaseIndonesia
-
Hospices Civils de LyonCompletedEmergency Department Staff During the COVID-19 Pandemic | Emergency Department Staff's Level of StressFrance